1020 related articles for article (PubMed ID: 16878047)
41. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
[TBL] [Abstract][Full Text] [Related]
42. Risk factors and causes of death in the Australian HIV Observational Database.
Petoumenos K; Law MG;
Sex Health; 2006 May; 3(2):103-12. PubMed ID: 16800396
[TBL] [Abstract][Full Text] [Related]
43. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
[TBL] [Abstract][Full Text] [Related]
44. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
[TBL] [Abstract][Full Text] [Related]
45. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.
Smith DK; Gardner LI; Phelps R; Hamburger ME; Carpenter C; Klein RS; Rompalo A; Schuman P; Holmberg SD;
J Urban Health; 2003 Dec; 80(4):676-88. PubMed ID: 14709715
[TBL] [Abstract][Full Text] [Related]
46. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients.
Antiretroviral Therapy Cohort Collaboration
J Acquir Immune Defic Syndr; 2007 Dec; 46(5):607-15. PubMed ID: 18043315
[TBL] [Abstract][Full Text] [Related]
47. A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study.
Leierer G; Rieger A; Schmied B; Sarcletti M; Öllinger A; Wallner E; Egle A; Kanatschnig M; Zoufaly A; Atzl M; Rappold M; El-Khatib Z; Ledergerber B; Zangerle R; On Behalf Of The Austrian Hiv Cohort Study Group
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886257
[TBL] [Abstract][Full Text] [Related]
48. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C and progression of HIV disease.
Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
[TBL] [Abstract][Full Text] [Related]
50. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.
Murphy EL; Collier AC; Kalish LA; Assmann SF; Para MF; Flanigan TP; Kumar PN; Mintz L; Wallach FR; Nemo GJ;
Ann Intern Med; 2001 Jul; 135(1):17-26. PubMed ID: 11434728
[TBL] [Abstract][Full Text] [Related]
51. Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.
Lartey M; Asante-Quashie A; Essel A; Kenu E; Ganu V; Neequaye A
Ghana Med J; 2015 Mar; 49(1):7-11. PubMed ID: 26339078
[TBL] [Abstract][Full Text] [Related]
52. [Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013].
Chen S; Ma L; Lu X; Li Y; Wang W; Wang Y; Zhao C; Zhang Y; Zhao H
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):460-4. PubMed ID: 26080634
[TBL] [Abstract][Full Text] [Related]
53. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
Am J Epidemiol; 2013 Jan; 177(2):116-25. PubMed ID: 23287403
[TBL] [Abstract][Full Text] [Related]
54. The HIV epidemic in Greenland--a slow spreading infection among adult heterosexual Greenlanders.
Bjorn-Mortensen K; Ladefoged K; Obel N; Helleberg M
Int J Circumpolar Health; 2013; 72():19558. PubMed ID: 23431117
[TBL] [Abstract][Full Text] [Related]
55. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
56. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
57. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
[TBL] [Abstract][Full Text] [Related]
58. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Egger M; May M; Chêne G; Phillips AN; Ledergerber B; Dabis F; Costagliola D; D'Arminio Monforte A; de Wolf F; Reiss P; Lundgren JD; Justice AC; Staszewski S; Leport C; Hogg RS; Sabin CA; Gill MJ; Salzberger B; Sterne JA;
Lancet; 2002 Jul; 360(9327):119-29. PubMed ID: 12126821
[TBL] [Abstract][Full Text] [Related]
59. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
60. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
